Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Priti Vohra

Interventional Pain Medicine Sarasota, FL Doctor of Osteopathy

NPI 1558524017 CMS profile 24900

2830 Bee Ridge Rd, Sarasota, FL 34239

Open in the dashboard

General payments

$15,948

733 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Priti Vohra of Sarasota, FL is reported in the CMS Open Payments database as having received $15,948 across 733 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $298 10
2024 General $330 9
2023 General $1,499 67
2022 General $4,060 205
2021 General $4,457 189
2020 General $2,235 98
2019 General $3,069 155

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Priti Vohra
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Priti Vohra were reported at $298. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Priti Vohra Interventional Pain Medicine median Middle half National median
2019 $3,069 $684 $216–$2,079 $163
2020 $2,235 $382 $122–$1,109 $114
2021 $4,457 $552 $167–$1,554 $132
2022 $4,060 $605 $187–$1,924 $149
2023 $1,499 $671 $195–$1,915 $160
2024 $330 $684 $206–$1,837 $164
2025 $298 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $3,707 122 payments
  2. Nevro Corp. $3,122 98 payments
  3. AbbVie, Inc. $1,848 106 payments
  4. Medtronic USA, Inc. $1,111 76 payments
  5. Abbott Laboratories $869 24 payments
  6. Medtronic, Inc. $763 29 payments
  7. Allergan Inc. $762 49 payments
  8. Horizon Therapeutics plc $740 46 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $373 33 payments
  10. Pfizer Inc. $369 19 payments
  11. Other $2,284 131 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,942 732 payments
  2. Travel and Lodging $6 1 payment
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $1,431 50 payments
  2. Omnia $1,196 37 payments
  3. BOTOX $1,185 73 payments
  4. QULIPTA $900 51 payments
  5. WaveWriter Alpha Prime 16 $650 21 payments
  6. NURTEC ODT $611 47 payments
  7. GENERAL PAIN MANAGEMENT $585 18 payments
  8. General - Pain Management $583 26 payments
  9. RAYOS Rayos $555 33 payments
  10. RAYOS Rayos $555 33 payments
  11. Other $8,906 414 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

733 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record